High efficacy of Azacitidine plus HAG in acute myeloid leukemia: an open-label, single-arm, multi-center, phase 2 study

Li, J., Han, Q., Huang, Y., Wei, Y., Zi, J., Zhao, L., … Ge, Z. (2022, October 1). High efficacy of Azacitidine plus HAG in acute myeloid leukemia: an open-label, single-arm, multi-center, phase 2 study. Blood Cancer Journal. Springer Nature. https://doi.org/10.1038/s41408-022-00740-3